1,323
Views
89
CrossRef citations to date
0
Altmetric
Articles

EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling

, , , , , , , , & show all
Pages 107-116 | Received 12 Oct 2011, Accepted 11 Dec 2011, Published online: 20 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Siavash Foroughi, Jeanne Tie, Peter Gibbs & Antony Wilks Burgess. (2019) Epidermal growth factor receptor ligands: targets for optimizing treatment of metastatic colorectal cancer. Growth Factors 37:5-6, pages 209-225.
Read now
J. Ødegård, J. E. Sondresen, M. Aasrum, I. H. Tveteraas, T. K. Guren, T. Christoffersen & G. H. Thoresen. (2017) Differential effects of epidermal growth factor (EGF) receptor ligands on receptor binding, downstream signalling pathways and DNA synthesis in hepatocytes. Growth Factors 35:6, pages 239-248.
Read now
Stine Louise Jeppe Knudsen, Anni Sieu Wai Mac, Lasse Henriksen, Bo van Deurs & Lene Melsæther Grøvdal. (2014) EGFR signaling patterns are regulated by its different ligands. Growth Factors 32:5, pages 155-163.
Read now

Articles from other publishers (86)

Jung-Chien Cheng, Qingxue Meng, Qian Zhang, Lingling Zhang, Jiaye Chen, Tinglin Song, Lanlan Fang & Ying-Pu Sun. (2023) WNK1 mediates amphiregulin-induced MMP9 expression and cell invasion in human extravillous trophoblast cells. Molecular and Cellular Endocrinology 576, pages 112038.
Crossref
Fenge Li, Huancheng Wu, Xueming Du, Yimo Sun, Barbara Nassif Rausseo, Amjad Talukder, Arjun Katailiha, Lama Elzohary, Yupeng Wang, Zhiyu Wang & Gregory Lizée. (2023) Epidermal Growth Factor Receptor-Targeted Neoantigen Peptide Vaccination for the Treatment of Non-Small Cell Lung Cancer and Glioblastoma. Vaccines 11:9, pages 1460.
Crossref
Mateusz Kciuk, Manzar Alam, Nemat Ali, Summya Rashid, Pola Głowacka, Rajamanikandan Sundaraj, Ismail Celik, Esam Bashir Yahya, Amit Dubey, Enfale Zerroug & Renata Kontek. (2023) Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications. Molecules 28:13, pages 5246.
Crossref
Claudia Catapano, Johanna V. Rahm, Marjan Omer, Laura Teodori, Jørgen Kjems, Marina S. Dietz & Mike Heilemann. (2023) Biased activation of the receptor tyrosine kinase HER2. Cellular and Molecular Life Sciences 80:6.
Crossref
Kenta Nishitani, Koji Hayakawa & Satoshi Tanaka. (2023) Epidermal growth factor represses differentiation of mouse trophoblast stem cells into spongiotrophoblast cells via epidermal growth factor receptor. Biochemical and Biophysical Research Communications 657, pages 100-107.
Crossref
Ivana Steiner, Teresita del N.J. Flores-Tellez, Renaud Mevel, Amin Ali, Pengbo Wang, Pieta Schofield, Caron Behan, Nicholas Forsythe, Garry Ashton, Catherine Taylor, Ian G. Mills, Pedro Oliveira, Simon S. McDade, Dietmar M. Zaiss, Ananya Choudhury, Georges Lacaud & Esther Baena. (2023) Autocrine activation of MAPK signaling mediates intrinsic tolerance to androgen deprivation in LY6D prostate cancer cells. Cell Reports 42:4, pages 112377.
Crossref
Marc Wiesehöfer, Benedikt Bernhard Gereon Raczinski, Caroline Wiesehöfer, Jaroslaw Thomas Dankert, Elena Dilara Czyrnik, Martin Spahn, Marianna Kruithof-de Julio & Gunther Wennemuth. (2023) Epiregulin expression and secretion is increased in castration-resistant prostate cancer. Frontiers in Oncology 13.
Crossref
Dehan Comez, Jacqueline Glenn, Stephanie M. Anbuhl, Raimond Heukers, Martine J. Smit, Stephen J. Hill & Laura E. Kilpatrick. (2022) Fluorescently tagged nanobodies and NanoBRET to study ligand-binding and agonist-induced conformational changes of full-length EGFR expressed in living cells. Frontiers in Immunology 13.
Crossref
Lauren M. Lucas, Vipasha Dwivedi, Jared I. Senfeld, Richard L. Cullum, Christopher P. Mill, J. Tyler Piazza, Ianthe N. Bryant, Laura J. Cook, S. Tyler Miller, James H. LottIVIV, Connor M. Kelley, Elizabeth L. Knerr, Jessica A. Markham, David P. Kaufmann, Megan A. Jacobi, Jianzhong Shen & David J. RieseIIII. (2022) The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein. Pharmacological Reviews 74:1, pages 18-47.
Crossref
Susanne Scheipl, Michelle Barnard, Birgit Lohberger, Richard Zettl, Iva Brcic, Bernadette Liegl-Atzwanger, Beate Rinner, Claudia Meindl & Eleonore Fröhlich. (2021) Drug combination screening as a translational approach toward an improved drug therapy for chordoma. Cellular Oncology 44:6, pages 1231-1242.
Crossref
Louise Pinet, Nadine Assrir & Carine van Heijenoort. (2021) Expanding the Disorder-Function Paradigm in the C-Terminal Tails of Erbbs. Biomolecules 11:11, pages 1690.
Crossref
Lanlan Fang, Sijia Wang, Xiaoyu Han, Yibo Gao, Yuxi Li, Jung-Chien Cheng & Ying-Pu Sun. (2021) Amphiregulin stimulates human chorionic gonadotropin expression by inducing ERK1/2-mediated ID3 expression in trophoblast cells. Placenta 112, pages 73-80.
Crossref
Christopher J.M. Williams, Jenny F. Seligmann, Faye Elliott, Michael Shires, Susan D. Richman, Sarah Brown, Liping Zhang, Shalini Singh, Judith Pugh, Xiao-Meng Xu, Andrea Muranyi, Christoph Guetter, Auranuch Lorsakul, Uday Kurkure, Zuo Zhao, Jim Martin, Xingwei Wang, Kien Nguyen, Wen-Wei Liu, Dongyao Yan, Nicholas P. West, Jennifer H. Barrett, Michael Barnes, Isaac Bai, Matthew T. Seymour, Philip Quirke & Kandavel Shanmugam. (2021) Artificial Intelligence–Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer . Clinical Cancer Research 27:12, pages 3422-3431.
Crossref
Olga Zbodakova, Karel Chalupsky, Lenka Sarnova, Petr Kasparek, Marketa Jirouskova, Martin Gregor & Radislav Sedlacek. (2021) ADAM10 and ADAM17 regulate EGFR, c-Met and TNF RI signalling in liver regeneration and fibrosis. Scientific Reports 11:1.
Crossref
Malak Sabbah, Ahmad Najem, Mohammad Krayem, Ahmad Awada, Fabrice Journe & Ghanem E. Ghanem. (2021) RTK Inhibitors in Melanoma: From Bench to Bedside. Cancers 13:7, pages 1685.
Crossref
Jun Zhao, Nishant Mohan, Ruth Nussinov, Buyong Ma & Wen Jin Wu. (2021) Trastuzumab Blocks the Receiver Function of HER2 Leading to the Population Shifts of HER2-Containing Homodimers and Heterodimers. Antibodies 10:1, pages 7.
Crossref
Wen-Hsuan Chang, Richard A. Cerione & Marc A. Antonyak. 2021. Cancer Cell Signaling. Cancer Cell Signaling 143 170 .
Rebecca C. Feiner, Isabell Kemker, Lea Krutzke, Ellen Allmendinger, Daniel J. Mandell, Norbert Sewald, Stefan Kochanek & Kristian M. Müller. (2020) EGFR-Binding Peptides: From Computational Design towards Tumor-Targeting of Adeno-Associated Virus Capsids. International Journal of Molecular Sciences 21:24, pages 9535.
Crossref
Laura C. Zanetti-Domingues, Scott E. Bonner, R. Sumanth Iyer, Marisa L. Martin-Fernandez & Veronica Huber. (2020) Cooperation and Interplay between EGFR Signalling and Extracellular Vesicle Biogenesis in Cancer. Cells 9:12, pages 2639.
Crossref
Srija Mukhopadhyay, Sahana Ghosh, Debodipta Das, P. Arun, Bidyut Roy, Nidhan K. Biswas, Arindam Maitra & Partha P. Majumder. (2020) Application of Random Forest and data integration identifies three dysregulated genes and enrichment of Central Carbon Metabolism pathway in Oral Cancer. BMC Cancer 20:1.
Crossref
Laura C. Zanetti-Domingues, Scott E. Bonner, Marisa L. Martin-Fernandez & Veronica Huber. (2020) Mechanisms of Action of EGFR Tyrosine Kinase Receptor Incorporated in Extracellular Vesicles. Cells 9:11, pages 2505.
Crossref
Michael Rose, Angela Maurer, Julia Wirtz, Andreas Bleilevens, Tanja Waldmann, Maximilian Wenz, Marie Eyll, Mirja Geelvink, Melanie Gereitzig, Nadine Rüchel, Bernd Denecke, Elke Eltze, Edwin Herrmann, Marieta Toma, David Horst, Tobias Grimm, Stefan Denzinger, Thorsten Ecke, Thomas Alexander Vögeli, Ruth Knuechel, Jochen Maurer & Nadine T. Gaisa. (2020) EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer. Oncogene 39:44, pages 6856-6870.
Crossref
Khosbayar Lkhagvadorj, Zhijun Zeng, Juan Song, Marjan Reinders-Luinge, Wierd Kooistra, Shanshan Song, Susanne Krauss-Etschmann, Barbro N. Melgert, Junjun Cao & Machteld N. Hylkema. (2020) Prenatal smoke exposure dysregulates lung epithelial cell differentiation in mouse offspring: role for AREG-induced EGFR signaling. American Journal of Physiology-Lung Cellular and Molecular Physiology 319:4, pages L742-L751.
Crossref
Anatoly Kiyatkin, Iris K. van Alderwerelt van RosenburghDaryl E. KleinMark A. Lemmon. (2020) Kinetics of receptor tyrosine kinase activation define ERK signaling dynamics. Science Signaling 13:645.
Crossref
Barbara Colella, Mayra Colardo, Gianna Iannone, Claudia Contadini, Cristina Saiz-Ladera, Claudia Fuoco, Daniela Barilà, Guillermo Velasco, Marco Segatto & Sabrina Di Bartolomeo. (2020) mTOR Inhibition Leads to Src-Mediated EGFR Internalisation and Degradation in Glioma Cells. Cancers 12:8, pages 2266.
Crossref
Raphael Trenker & Natalia Jura. (2020) Receptor tyrosine kinase activation: From the ligand perspective. Current Opinion in Cell Biology 63, pages 174-185.
Crossref
Emanuel Salazar-Cavazos, Carolina Franco Nitta, Eshan D. Mitra, Bridget S. Wilson, Keith A. Lidke, William S. Hlavacek & Diane S. Lidke. (2020) Multisite EGFR phosphorylation is regulated by adaptor protein abundances and dimer lifetimes. Molecular Biology of the Cell 31:7, pages 695-708.
Crossref
Rakesh Kumar, Bijesh George, Marcia R. Campbell, Nandini Verma, Aswathy Mary Paul, Cecília Melo-Alvim, Leonor Ribeiro, M. Radhakrishna Pillai, Luis Marques da Costa & Mark M. Moasser. 2020. Receptor Tyrosine Kinases. Receptor Tyrosine Kinases 109 160 .
Eirini Kefaloyianni, Manikanda Raja Keerthi Raja, Julian Schumacher, Muthu Lakshmi Muthu, Vaishali Krishnadoss, Sushrut S. Waikar & Andreas Herrlich. (2019) Proximal Tubule–Derived Amphiregulin Amplifies and Integrates Profibrotic EGF Receptor Signals in Kidney Fibrosis. Journal of the American Society of Nephrology 30:12, pages 2370-2383.
Crossref
Shiqi Ma, Shijun Jia, Yuan Ren, Bangrong Cao, Xiao Zha, Jintao He & Changmin Chen. (2019) ErbB3 Ligand Heregulin1 Is a Major Mitogenic Factor for Uncontrolled Lung Cancer Cell Proliferation. Neoplasia 21:4, pages 343-352.
Crossref
Ruth A. Mitchell, Rodney B. Luwor & Antony W. Burgess. (2018) Epidermal growth factor receptor: Structure-function informing the design of anticancer therapeutics. Experimental Cell Research 371:1, pages 1-19.
Crossref
Julie K.L. Sinclair, Allison S. Walker, Amy E. Doerner & Alanna Schepartz. (2018) Mechanism of Allosteric Coupling into and through the Plasma Membrane by EGFR. Cell Chemical Biology 25:7, pages 857-870.e7.
Crossref
Jeongyeon Heo, Jae Geun Kim, Sunghwan Kim & Hara Kang. (2018) Stat5 phosphorylation is responsible for the excessive potency of HB‐EGF. Journal of Cellular Biochemistry 119:7, pages 5297-5307.
Crossref
Kenneth R. Durbin, Colin Phipps & Xiaoli Liao. (2018) Mechanistic Modeling of Antibody–Drug Conjugate Internalization at the Cellular Level Reveals Inefficient Processing Steps. Molecular Cancer Therapeutics 17:6, pages 1341-1351.
Crossref
Sarah C. McDermott, Christie Rodriguez-Ramirez, Sean P. McDermott, Max S. Wicha & Jacques E. Nör. (2018) FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin. Oncotarget 9:38, pages 25148-25165.
Crossref
Giusi Caldieri, Maria Grazia Malabarba, Pier Paolo Di Fiore & Sara Sigismund. 2018. Endocytosis and Signaling. Endocytosis and Signaling 235 272 .
Sara Sigismund, Daniele Avanzato & Letizia Lanzetti. (2017) Emerging functions of the EGFR in cancer . Molecular Oncology 12:1, pages 3-20.
Crossref
Daniel M. Freed, Nicholas J. Bessman, Anatoly Kiyatkin, Emanuel Salazar-Cavazos, Patrick O. Byrne, Jason O. Moore, Christopher C. Valley, Kathryn M. Ferguson, Daniel J. Leahy, Diane S. Lidke & Mark A. Lemmon. (2017) EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics. Cell 171:3, pages 683-695.e18.
Crossref
Endang Purba, Ei-ichiro Saita & Ichiro Maruyama. (2017) Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The “Rotation Model”. Cells 6:2, pages 13.
Crossref
Xiuling Xu, Wenshu Chen, Shuguang Leng, Mabel T Padilla, Bryanna Saxton, Julie Hutt, Mathewos Tessema, Kosuke Kato, Kwang Chul Kim, Steven A Belinsky & Yong Lin. (2017) Muc1 knockout potentiates murine lung carcinogenesis involving an epiregulin-mediated EGFR activation feedback loop. Carcinogenesis 38:6, pages 604-614.
Crossref
Hannah M Brown, Kylie R Dunning, Melanie Sutton-McDowall, Robert B Gilchrist, Jeremy G Thompson & Darryl L Russell. (2017) Failure to launch: aberrant cumulus gene expression during oocyte in vitro maturation. Reproduction 153:3, pages R109-R120.
Crossref
Kai Liu, Dongdong Lin, Yabo Ouyang, Lijun Pang, Xianghua Guo, Shanshan Wang, Yunjin Zang & Dexi Chen. (2017) Amphiregulin impairs apoptosis-stimulating protein 2 of p53 overexpression–induced apoptosis in hepatoma cells. Tumor Biology 39:3, pages 101042831769502.
Crossref
Wu-Lin Zuo, Jing Yang, Kazunori Gomi, IonWa Chao, Ronald G. Crystal & Renat Shaykhiev. (2017) EGF-Amphiregulin Interplay in Airway Stem/Progenitor Cells Links the Pathogenesis of Smoking-Induced Lesions in the Human Airway Epithelium. Stem Cells 35:3, pages 824-837.
Crossref
Jamila Irgasheva, Iman Aldybiat, Firuz Shukurov & Massoud Mirshahi. (2017) PHYSIOLOGICAL ROLE OF BONE MARROW ADULT STEM CELL CD133+. AVICENNA BULLETIN 19:2, pages 177-182.
Crossref
Yongchao Wang, Mei Xu, Zun-ji Ke & Jia Luo. (2017) Cellular and molecular mechanisms underlying alcohol-induced aggressiveness of breast cancer. Pharmacological Research 115, pages 299-308.
Crossref
Jung-Chien Cheng, Hsun-Ming Chang, Siyuan Xiong, Wai-Kin So & Peter C. K. Leung. (2016) Sprouty2 inhibits amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells. Oncotarget 7:49.
Crossref
Gisela Nilsson & Marie Kannius-Janson. (2016) Forkhead Box F1 promotes breast cancer cell migration by upregulating lysyl oxidase and suppressing Smad2/3 signaling. BMC Cancer 16:1.
Crossref
Chiara Corrado, Laura Saieva, Stefania Raimondo, Alessandra Santoro, Giacomo De Leo & Riccardo Alessandro. (2016) Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor. Journal of Cellular and Molecular Medicine 20:10, pages 1829-1839.
Crossref
Jerusa A.Q.A. Faria, Carolina de Andrade, Alfredo M. Goes, Michele A. Rodrigues & Dawidson A. Gomes. (2016) Effects of different ligands on epidermal growth factor receptor (EGFR) nuclear translocation. Biochemical and Biophysical Research Communications 478:1, pages 39-45.
Crossref
Mariana Tamazato Longhi, Magna Magalhães, Jeffrey Reina, Vanessa Morais Freitas & Nathalie Cella. (2016) EGFR Signaling Regulates Maspin/SerpinB5 Phosphorylation and Nuclear Localization in Mammary Epithelial Cells. PLOS ONE 11:7, pages e0159856.
Crossref
Tom Ronan, Jennifer L. Macdonald-Obermann, Lorel Huelsmann, Nicholas J. Bessman, Kristen M. Naegle & Linda J. Pike. (2016) Different Epidermal Growth Factor Receptor (EGFR) Agonists Produce Unique Signatures for the Recruitment of Downstream Signaling Proteins. Journal of Biological Chemistry 291:11, pages 5528-5540.
Crossref
Yangmi Lim, Jiho Yoo, Min-Soo Kim, Minkyu Hur, Eun Hee Lee, Hyung-Suk Hur, Jae-Chul Lee, Shi-Nai Lee, Tae Wook Park, Kyuhyun Lee, Ki Hwan Chang, Kuglae Kim, YingJin Kang, Kwang-Won Hong, Se-Ho Kim, Yeon-Gil Kim, Yeup Yoon, Do-Hyun Nam, Heekyoung Yang, Dong Geon Kim, Hyun-Soo Cho & Jonghwa Won. (2016) GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands. Molecular Cancer Therapeutics 15:2, pages 251-263.
Crossref
S Carvalho, M Lindzen, M Lauriola, N Shirazi, S Sinha, A Abdul-Hai, K Levanon, J Korach, I Barshack, Y Cohen, A Onn, G Mills & Y Yarden. (2015) An antibody to amphiregulin, an abundant growth factor in patients’ fluids, inhibits ovarian tumors. Oncogene 35:4, pages 438-447.
Crossref
A. Conte & S. Sigismund. 2016. Ubiquitination and Transmembrane Signaling. Ubiquitination and Transmembrane Signaling 225 276 .
Ju-Fang Liu, Ya-Ting Tsao & Chun-Han Hou. (2015) Amphiregulin enhances intercellular adhesion molecule-1 expression and promotes tumor metastasis in human osteosarcoma. Oncotarget 6:38, pages 40880-40895.
Crossref
Jeffrey D. Kearns, Raghida Bukhalid, Mark Sevecka, Gege Tan, Nastaran Gerami-Moayed, Shannon L. Werner, Neeraj Kohli, Olga Burenkova, Callum M. Sloss, Anne M. King, Jonathan B. Fitzgerald, Ulrik B. Nielsen & Beni B. Wolf. (2015) Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic. Molecular Cancer Therapeutics 14:7, pages 1625-1636.
Crossref
Amy Doerner, Rebecca Scheck & Alanna Schepartz. (2015) Growth Factor Identity Is Encoded by Discrete Coiled-Coil Rotamers in the EGFR Juxtamembrane Region. Chemistry & Biology 22:6, pages 776-784.
Crossref
Kylie R. Dunning, Laura N. Watson, Voueleng J. Zhang, Hannah M. Brown, Adrian K. Kaczmarek, Rebecca L. Robker & Darryl L. Russell. (2015) Activation of Mouse Cumulus-Oocyte Complex Maturation In Vitro Through EGF-Like Activity of Versican1. Biology of Reproduction 92:5.
Crossref
Chad McKee, Barbara Sigala, Junpei Soeda, Angelina Mouralidarane, Maelle Morgan, Gianluigi Mazzoccoli, Francesca Rappa, Francesco Cappello, Daniela Cabibi, Valerio Pazienza, Claire Selden, Tania Roskams, Manlio Vinciguerra & Jude A. Oben. (2015) Amphiregulin activates human hepatic stellate cells and is upregulated in non alcoholic steatohepatitis. Scientific Reports 5:1.
Crossref
Timothy G. Curran, Yi Zhang, Daniel J. Ma, Jann N. Sarkaria & Forest M. White. (2015) MARQUIS: A multiplex method for absolute quantification of peptides and posttranslational modifications. Nature Communications 6:1.
Crossref
Anthony W. Norman & Helen L. Henry. 2015. Hormones. Hormones 363 379 .
Mattia Lauriola, Yehoshua Enuka, Amit Zeisel, Gabriele D’Uva, Lee Roth, Michal Sharon-Sevilla, Moshit Lindzen, Kirti Sharma, Nava Nevo, Morris Feldman, Silvia Carvalho, Hadas Cohen-Dvashi, Merav Kedmi, Nir Ben-Chetrit, Alon Chen, Rossella Solmi, Stefan Wiemann, Fernando Schmitt, Eytan Domany & Yosef Yarden. (2014) Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment. Nature Communications 5:1.
Crossref
Antonella De Luca, Cristin Roma, Marianna Gallo, Francesca Fenizia, Francesca Bergantino, Daniela Frezzetti, Susan Costantini & Nicola Normanno. (2014) RNA-seq analysis reveals significant effects of EGFR signalling on the secretome of mesenchymal stem cells. Oncotarget 5:21, pages 10518-10528.
Crossref
Christina L. Austin, Sathiya N. Manivannan & Amanda Simcox. (2014) TGF-α ligands can substitute for the neuregulin Vein in Drosophila development . Development 141:21, pages 4110-4114.
Crossref
Jennifer L. Macdonald-Obermann & Linda J. Pike. (2014) Different Epidermal Growth Factor (EGF) Receptor Ligands Show Distinct Kinetics and Biased or Partial Agonism for Homodimer and Heterodimer Formation. Journal of Biological Chemistry 289:38, pages 26178-26188.
Crossref
Tai KiuchiElena Ortiz-ZapaterJames MonypennyDaniel R. MatthewsLan K. NguyenJody BarbeauOana CobanKatherine LawlerBrian BurfordDaniel J. RolfeEmanuele de RinaldisDimitra DafouMichael A. SimpsonNatalie WoodmanSarah PinderCheryl E. GillettViviane DevaugesSimon P. PolandGilbert FruhwirthPierfrancesco MarraYkelien L. BoersmaAndreas PlückthunWilliam J. GullickYosef YardenGeorge SantisMartyn WinnBoris N. KholodenkoMarisa L. Martin-FernandezPeter ParkerAndrew TuttSimon M. Ameer-BegTony Ng. (2014) The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility. Science Signaling 7:339.
Crossref
D. Propper, I. Davidenko, J. Bridgewater, L. Kupcinskas, A. Fittipaldo, C. Hillenbach, B. Klughammer & M. Ducreux. (2014) Phase II, randomized, biomarker identification trial (MARK) for erlotinib in patients with advanced pancreatic carcinoma. Annals of Oncology 25:7, pages 1384-1390.
Crossref
Z N Zhou, V P Sharma, B T Beaty, M Roh-Johnson, E A Peterson, N Van Rooijen, P A Kenny, H S Wiley, J S Condeelis & J E Segall. (2013) Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo. Oncogene 33:29, pages 3784-3793.
Crossref
Daniel J. Watkins, Yu Zhou, Mika A.B. Matthews, Li Chen & Gail E. Besner. (2014) HB-EGF augments the ability of mesenchymal stem cells to attenuate intestinal injury. Journal of Pediatric Surgery 49:6, pages 938-944.
Crossref
Ravi Birla. 2014. Introduction to Tissue Engineering. Introduction to Tissue Engineering 40 83 .
Jinming Gu, Jinsong Yang, Qing Chang, Xiaoqing Lu, Jieyi Wang, Mingjiu Chen, Tariq Ghayur & Jijie Gu. (2014) Identification of Anti-ErbB2 Dual Variable Domain Immunoglobulin (DVD-Ig™) Proteins with Unique Activities. PLoS ONE 9:5, pages e97292.
Crossref
David J. RieseIIII & Richard L. Cullum. (2014) Epiregulin: Roles in normal physiology and cancer. Seminars in Cell & Developmental Biology 28, pages 49-56.
Crossref
Carmen Berasain & Matías A. Avila. (2014) Amphiregulin. Seminars in Cell & Developmental Biology 28, pages 31-41.
Crossref
Lawrence A. SchevingXiuqi ZhangOscar A. GarciaRebecca F. WangMary C. StevensonDavid W. Threadgill & William E. Russell. (2014) Epidermal growth factor receptor plays a role in the regulation of liver and plasma lipid levels in adult male mice. American Journal of Physiology-Gastrointestinal and Liver Physiology 306:5, pages G370-G381.
Crossref
Dulama Richani, Melanie L. Sutton-McDowall, Laura A. Frank, Robert B. Gilchrist & Jeremy G. Thompson. (2014) Effect of Epidermal Growth Factor-Like Peptides on the Metabolism of In Vitro- Matured Mouse Oocytes and Cumulus Cells1. Biology of Reproduction 90:3.
Crossref
Wei Bin Fang, Min Yao & Nikki Cheng. (2014) Priming cancer cells for drug resistance: role of the fibroblast niche. Frontiers in Biology 9:2, pages 114-126.
Crossref
Carmen Berasain & Matías A. Avila. (2013) The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis. Journal of Gastroenterology 49:1, pages 9-23.
Crossref
Marc A. Antonyak & Richard A. Cerione. 2014. Cancer Cell Signaling. Cancer Cell Signaling 147 173 .
D. Richani, L. J. Ritter, J. G. Thompson & R. B. Gilchrist. (2013) Mode of oocyte maturation affects EGF-like peptide function and oocyte competence. Molecular Human Reproduction 19:8, pages 500-509.
Crossref
Nicole M. Mackey-Lawrence, Xiaoti Guo, Daniel E. Sturdevant, Kimmo Virtaneva, Matthew M. Hernandez, Eric Houpt, Alan Sher, Stephen F. Porcella & William A. PetriJr.Jr.. (2013) Effect of the Leptin Receptor Q223R Polymorphism on the Host Transcriptome following Infection with Entamoeba histolytica. Infection and Immunity 81:5, pages 1460-1470.
Crossref
Lasse Henriksen, Michael Vibo Grandal, Stine Louise Jeppe Knudsen, Bo van Deurs & Lene Melsæther Grøvdal. (2013) Internalization Mechanisms of the Epidermal Growth Factor Receptor after Activation with Different Ligands. PLoS ONE 8:3, pages e58148.
Crossref
Ubaidullo Kurbonov, Abdusamad Dustov, Alisher Barotov, Murtazokul Khidirov, Giesidin Mirojov, Zikrie Rahimov, Navjuvon Navjuvonov, Eraj Rizoev, Nasim Olimov, Alijon Goibov, Bakhtovar Karim-Zade, Mukim Rakhmatov, Suhayli Muminjonov, Azadeh Didari, Jamila Irgasheva, Oktam Bobokhojaev, Tashpulat Gulmuradov, Amu Therwath, Sohibnazar Rakhmonov & Massoud Mirshahi. (2013) Intracoronary Infusion of Autologous CD133 + Cells in Myocardial Infarction and Tracing by Tc99m MIBI Scintigraphy of the Heart Areas Involved in Cell Homing . Stem Cells International 2013, pages 1-9.
Crossref
Sergio Anastasi, Stefano Alemà & Oreste Segatto. 2013. Vesicle Trafficking in Cancer. Vesicle Trafficking in Cancer 279 302 .
Cheng Wang, Xiangmin Lv, Chao Jiang, Crystal M. Cordes, Lan Fu, Subodh M. Lele & John S. Davis. (2012) Transforming Growth Factor Alpha (TGF?) Regulates Granulosa Cell Tumor (GCT) Cell Proliferation and Migration through Activation of Multiple Pathways. PLoS ONE 7:11, pages e48299.
Crossref
Alexandra Collin de l'Hortet, Hélène Gilgenkrantz & Jacques-Emmanuel Guidotti. (2012) EGFR: A Master Piece in G1/S Phase Transition of Liver Regeneration. International Journal of Hepatology 2012, pages 1-9.
Crossref
Ivana Steiner, Teresita del N.J. Flores-Tellez, Renaud Mevel, Amin Ali, Pengbo Wang, Pieta Schofield, Nicholas Forsythe, Garry Ashton, Catherine Taylor, Ian G. Mills, Pedro Oliveira, Simon McDade, Dietmar Zeiss, Ananya Choudhury, Georges Lacaud & Esther Baena. (2021) Autocrine Activation of MAPK-Signaling Mediates Intrinsic Tolerance to Androgen Deprivation in LY6D Prostate Cancer Cells. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.